Stocks · Health care · Pharmaceutical Preparations

ANI PHARMACEUTICALS INC

ANIP Clue Score55
United States Fiscal year ends December CIK 0001023024 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Chad Gassert
21 Mar 2022
SVP - Corp. Dev. & Strategy
Buy indirect
5,000
$27.87
$139.34K
Patrick D Walsh
21 Mar 2022
Director
Buy
5,000
$27.76
$138.79K
Nikhil Lalwani
21 Mar 2022
President & CEO
Buy
7,224
$27.69
$200.00K
Chad Gassert
18 Mar 2022
SVP - Corp. Dev. & Strategy
Buy indirect
5,000
$27.15
$135.74K
Muthusamy Shanmugam
17 Mar 2022
Head of R&D, COO-Novitium Ops
Buy indirect
5,000
$27.65
$138.25K
Muthusamy Shanmugam
17 Mar 2022
Head of R&D, COO-Novitium Ops
Buy
5,000
$27.65
$138.25K
Jeanne Thoma
20 Dec 2021
Director
Buy
1,072
$46.47
$49.82K
Antonio R Pera
7 Dec 2021
Director
Buy
3,000
$42.26
$126.79K
Thomas Haughey
6 Dec 2021
Director
Buy
2,500
$39.38
$98.45K
Patrick D Walsh
15 Mar 2021
Director
Buy
4,000
$32.89
$131.56K
Patrick D Walsh
9 Nov 2020
Director
Buy
5,000
$25.96
$129.80K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
3,000
$30.89
$92.67K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
4,000
$30.98
$123.92K
Patrick D Walsh
10 Aug 2020
Chairman, Interim Pres. & CEO
Buy
3,000
$30.40
$91.20K
Thomas Haughey
4 Mar 2020
Director
Buy
3,000
$45.05
$135.15K
Thomas Haughey
3 Mar 2020
Director
Buy
2,000
$45.18
$90.36K
David Nash
24 May 2019
Director
Buy
1,445
$68.76
$99.36K
Thomas Haughey
15 May 2019
Director
Buy
2,500
$69.30
$173.24K
Showing 250 of 268 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 443
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 127
Sales straight out of an exercise 26
Sales at will 89
Transactions with no price 0
Shares from compensation/vesting 4,962,594
Sales filed before the plan box existed 37
History held since 29 Sep 2006